NO952336D0 - Insulin analoger - Google Patents

Insulin analoger

Info

Publication number
NO952336D0
NO952336D0 NO952336A NO952336A NO952336D0 NO 952336 D0 NO952336 D0 NO 952336D0 NO 952336 A NO952336 A NO 952336A NO 952336 A NO952336 A NO 952336A NO 952336 D0 NO952336 D0 NO 952336D0
Authority
NO
Norway
Prior art keywords
insulin analogues
analogues
insulin
Prior art date
Application number
NO952336A
Other languages
English (en)
Other versions
NO952336L (no
Inventor
Ronald Eugene Chance
Li Fan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO952336L publication Critical patent/NO952336L/no
Publication of NO952336D0 publication Critical patent/NO952336D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO952336A 1992-12-18 1995-06-13 Insulin analoger NO952336D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99565992A 1992-12-18 1992-12-18
PCT/US1993/012237 WO1994014461A1 (en) 1992-12-18 1993-12-15 Insulin analogs

Publications (2)

Publication Number Publication Date
NO952336L NO952336L (no) 1995-06-13
NO952336D0 true NO952336D0 (no) 1995-06-13

Family

ID=25542078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952336A NO952336D0 (no) 1992-12-18 1995-06-13 Insulin analoger

Country Status (14)

Country Link
EP (1) EP0605983A3 (no)
JP (1) JPH08504820A (no)
CN (1) CN1094059A (no)
AU (1) AU680462B2 (no)
BR (1) BR9307687A (no)
CA (1) CA2151134A1 (no)
CZ (1) CZ158895A3 (no)
FI (1) FI953001A (no)
HU (1) HUT71583A (no)
MX (1) MX9307991A (no)
NO (1) NO952336D0 (no)
PL (1) PL310007A1 (no)
WO (1) WO1994014461A1 (no)
ZA (1) ZA939477B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
AU2009305472B2 (en) 2008-10-17 2013-12-19 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a GLP-1 agonist
DK2498801T3 (en) 2009-11-13 2018-05-07 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION INCLUDING desPro36Exendin-4 (1-39) -Lys6-NH2 AND METHIONIN
EP2554183B1 (de) 2009-11-13 2018-04-04 Sanofi-Aventis Deutschland GmbH Pharmazeutische Zusammensetzung umfassend einen GLP-1-Agonisten, ein Insulin und Methionin
KR101823320B1 (ko) 2010-08-30 2018-01-31 사노피-아벤티스 도이칠란트 게엠베하 제２형 진성 당뇨병 치료용 약제를 제조하기 위한 ａｖｅ００１０의 용도
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP3395358B1 (en) * 2012-09-26 2019-11-06 Indiana University Research and Technology Corporation Insulin analog dimers
KR102578030B1 (ko) 2014-12-12 2023-09-14 사노피-아벤티스 도이칠란트 게엠베하 인슐린 글라진／릭시세나티드 고정비 제형
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
NO922376L (no) * 1991-06-21 1992-12-22 Lilly Co Eli Insulinanaloger

Also Published As

Publication number Publication date
EP0605983A3 (en) 1995-06-07
EP0605983A2 (en) 1994-07-13
NO952336L (no) 1995-06-13
WO1994014461A1 (en) 1994-07-07
AU680462B2 (en) 1997-07-31
FI953001A0 (fi) 1995-06-16
HU9501762D0 (en) 1995-08-28
BR9307687A (pt) 2002-02-19
CZ158895A3 (en) 1995-12-13
PL310007A1 (en) 1995-11-13
MX9307991A (es) 1994-08-31
JPH08504820A (ja) 1996-05-28
FI953001A (fi) 1995-06-16
CN1094059A (zh) 1994-10-26
ZA939477B (en) 1995-06-19
HUT71583A (en) 1995-12-28
AU5827994A (en) 1994-07-19
CA2151134A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
BR9305077A (pt) Seringa hipodémica
ATE237635T1 (de) Acylierte insulinanalogen
FI956308A0 (fi) Injektioruisku
DK186089D0 (da) Sproejter
FI104235B1 (fi) Ruisku
DE69222622D1 (de) Spritze
NO307167B1 (no) Ampulle
BR9306974A (pt) Seringa
DE59308356D1 (de) Spritze
FI953001A0 (fi) Insuliinianalogeja
FI943581A (fi) Ruisku
DE69304645D1 (de) Kanuele
DE69309570T2 (de) Spritze
NO922376L (no) Insulinanaloger
KR920021041U (ko) 세척기
NO950721D0 (no) Insulinanaloger
NO942783D0 (no) Spröyte
KR940001042U (ko) 앰플(Ampoule)
KR950008187U (ko) 화살식 동물 주사기
SE9202756D0 (sv) Spruta
BR9200932A (pt) Seringa
KR930017636U (ko) 세척기
DK265590A (da) Insulinanaloger
ATE100824T1 (de) Insulin-analoge.
NO904841D0 (no) Insulinanaloger.